USFDA Closes Zydus Inspection with NAI

  Published 11 months ago

USFDA inspection (Mar 10-14, 2025) closed as NAI; Zydus Lifesciences continues global healthcare operations.

  • Inspection concluded with no regulatory action needed.
  • Zydus discovers, develops, and markets diverse therapies worldwide.
  • Closure confirms compliance and operational standards met.

You might like these

Tolins Tyres Surges 9.3% on Production Growth

Coal India Stock Surges on IPO News

IKS Health posts robust Q2 growth

Paytm Rises Ahead of Q1 Results

OPEC Sees India Energy Demand Surge

IndiGo Stock Rises on HSBC Upgrade, Record High

India Boosts Semiconductor Manufacturing with SEZ Reforms

News that matters the most ⚡